Scholarlink

Background <p>Opioid-related hospitalizations are highly prevalent. Hospital-based clinicians are well positioned to initiate medications for opioid use disorder (MOUD) among hospitalized adults with OUD.</p> Objective <p>Measure the perceived impact of a multi-site and multi-faceted OUD intervention to expand provision of hospital-based OUD treatment, including MOUD.</p> Design, Participants, and Setting <p>Compared pre- and post-OUD intervention survey results of hospital-based clinicians practicing across 12 hospitals following implementation of an OUD intervention.</p> Measures <p>Survey questions were grouped into six domains: evidence to treat OUD; hospital processes to screen for unhealthy substance use and refer to post-discharge OUD treatment; MOUD initiation; readiness to initiate MOUD; current practices to initiate MOUD; and leadership prioritization of OUD treatment. We calculated mean summary scores across domains and measured changes across pre- and post-OUD intervention surveys. We analyzed open-ended survey questions using a team-based content analysis to identify and quantify key concepts.</p> Key Results <p>Of the 213 post-OUD intervention survey respondents (61% response rate), 110 (52%) also completed the pre-survey. Compared to the pre-survey, in the post-survey, more respondents reported believing that the evidence to treat OUD was valid (<i>p</i> &lt; 0.001), reported higher satisfaction with hospital processes to screen and refer to OUD treatment (<i>p</i> &lt; 0.001), reported fewer concerns regarding MOUD initiation (buprenorphine: <i>p</i> &lt; 0.001; methadone: <i>p</i> &lt; 0.001), reported that leadership prioritized OUD treatment (<i>p</i> &lt; 0.001), and reported higher readiness to initiate MOUD (buprenorphine: <i>p</i> &lt; 0.001; methadone: <i>p</i> &lt; 0.001). Fewer respondents reported barriers to initiate buprenorphine (<i>p</i> = 0.002) or methadone (<i>p</i> &lt; 0.001) in the hospital. Emergent key concepts from open-ended questions included a need for ongoing education and training to treat OUD and a need for access to addiction specialists (<i>n</i> = 50%; <i>n</i> = 28% of write-in responses, respectively).</p> Conclusion <p>Interventions to facilitate in-hospital OUD treatment should address local barriers to providing this care, including ensuring access to addiction specialists and providing routine and accessible education to hospital-based clinicians.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Measuring the Impact of a Multi-Site In-Hospital Intervention for Opioid Use Disorder Treatment Provision: A Survey of Hospital-Based Clinicians

  • 期刊论文

  • 发表日期：

    2025年8月27日

查看全文
  • Susan L. Calcaterra,
  • Steven Lockhart,
  • Crystal Natvig,
  • Susan K. Mikulich-Gilbertson

摘要

Background

Opioid-related hospitalizations are highly prevalent. Hospital-based clinicians are well positioned to initiate medications for opioid use disorder (MOUD) among hospitalized adults with OUD.

Objective

Measure the perceived impact of a multi-site and multi-faceted OUD intervention to expand provision of hospital-based OUD treatment, including MOUD.

Design, Participants, and Setting

Compared pre- and post-OUD intervention survey results of hospital-based clinicians practicing across 12 hospitals following implementation of an OUD intervention.

Measures

Survey questions were grouped into six domains: evidence to treat OUD; hospital processes to screen for unhealthy substance use and refer to post-discharge OUD treatment; MOUD initiation; readiness to initiate MOUD; current practices to initiate MOUD; and leadership prioritization of OUD treatment. We calculated mean summary scores across domains and measured changes across pre- and post-OUD intervention surveys. We analyzed open-ended survey questions using a team-based content analysis to identify and quantify key concepts.

Key Results

Of the 213 post-OUD intervention survey respondents (61% response rate), 110 (52%) also completed the pre-survey. Compared to the pre-survey, in the post-survey, more respondents reported believing that the evidence to treat OUD was valid (p < 0.001), reported higher satisfaction with hospital processes to screen and refer to OUD treatment (p < 0.001), reported fewer concerns regarding MOUD initiation (buprenorphine: p < 0.001; methadone: p < 0.001), reported that leadership prioritized OUD treatment (p < 0.001), and reported higher readiness to initiate MOUD (buprenorphine: p < 0.001; methadone: p < 0.001). Fewer respondents reported barriers to initiate buprenorphine (p = 0.002) or methadone (p < 0.001) in the hospital. Emergent key concepts from open-ended questions included a need for ongoing education and training to treat OUD and a need for access to addiction specialists (n = 50%; n = 28% of write-in responses, respectively).

Conclusion

Interventions to facilitate in-hospital OUD treatment should address local barriers to providing this care, including ensuring access to addiction specialists and providing routine and accessible education to hospital-based clinicians.